Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells

Kidney International

Volumn 56, Issue 2, 1999, Pages 461-470

  Gesualdo, Loreto ^a   Ranieri, Elena ^a   Monno, Raffaella ^a   Rossiello, Maria Rosaria ^a   Colucci, Mario ^a   Semeraro, Nicola ^a   Grandaliano, Giuseppe ^a   Schena, Francesco Paolo ^a   Ursi, Michele ^a   Cerullo, Giuseppina ^a  

^a Dipartimento di Scienze Biomediche   (Italy)

Author keywords

Angiotensin IV; Human proximal tubular cells; Interstitial fibrosis; PAI 1

Indexed keywords

AMASTATIN; ANGIOTENSIN; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE;

ARTICLE; CELL STIMULATION; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; DOSE RESPONSE; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0032810264     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00578.x     Document Type: Article

References (67)

1. 1. WOLF G, STAHL RA: Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1. Kidney Int 50:2112-2119, 1996
2. 2. WOLF G, MUELLER E, STAHL RA, ZIYADEH FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92:1366-1372, 1993
3. 3. WANG L, EBERHARD M, ERNE P: Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci 88:557-562, 1995
4. 4. RAIZADA MK, RYDZEWSKI B, LU D, SUMNERS C: Angiotensin II type 1 receptor-mediated stimulation of c-fos gene expression in astroglial cultures. Am J Physiol 265:C1046-C1049, 1993
5. 5. RAIZADA MK, LU D, YANG H, YU K: AT1-receptors and cellular actions of angiotensin II in neuronal cultures of stroke pronespontaneously hypertensive rat brain. Adv Exp Med Biol 396:71-78, 1996
6. 6. BAKER KM, ACETO JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259;H610-H618, 1990
7. 7. BROWN NJ, NADEAU JH, VAUGHAN DE: Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin. Thromb Haemost 77:522-525, 1997
8. 8. ALBRECHT D, BROSER M, KRUGER H, BADER M: Effects of angiotensin II and IV on geniculate activity in nontransgenic and transgenic rats. Eur J Pharmacol 332:53-63, 1997
9. 9. ARDAILLOU R, CHANSEL D: Synthesis and effects of active fragments of angiotensin II. Kidney Int 52:1458-1468, 1997
10. 10. WANG TT, WU XH, ZHANG SL, CHAN JS: Effect of glucose on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 53:312-319, 1998
11. 11. WANG L, LEI C, ZHANG SL, ROBERTS KD, TANG SS, INGELFINGER JR, CHAN JS: Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells. Kidney Int 53:287-295, 1998
12. 12. SEIKALY MG, ARANT BS JR, SENEY FD JR: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352-1357, 1990
13. 13. BRAAM B, MITCHELL KD, FOX J, NAVAR LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol 264:F891-F898, 1993
14. 14. SHIHAB FS, BENNETT WM, TANNER AM, ANDOH TF: Angiotensin II blockade decreases TGF-beta 1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660-673, 1997
15. 15. KAGAMI S, KUHARA T, OKADA K, KURODA Y, BORDER WA, NOBLE NA: Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells, Kidney Int 51:664-671, 1997
16. 16. WOLF G, ZIYADEH FN: Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 17:448-454, 1997
17. 17. GISEN GROUP: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857-1863, 1997
18. 18. KAMPER AL, HOLSTEIN-RATHLOU NH, LEYSSAC PP, STRANDGAARD S: The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy. Am J Kidney Dis 28:822-831, 1996
19. 19. KRAMER BK, SCHWEDA F: Ramipril in non-diabetic renal failure (REIN study): Ramipril Efficiency in Nephropathy study. (letter) Lancet 350:736, 1997
20. 20. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
21. 21. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JF, MOROLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945, 1996
22. 22. ZOJA C, CORNA D, BRUZZI I, FOGLIENI C, BERTANI T, REMUZZI G, BENIGNI A: Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 4:213-221, 1996
23. 23. ZOJA C, DONADELLI R, CORNA D, TESTA D, FACCHINETTI D, MAFFI R, LUZZANA E, COLOSIO V, BERTANI T, REMUZZI G: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264, 1997
24. 24. BLAIR-WEST JR, COGHLAN JP, DENTON DA, FUNDER JW, SCOGGINS BA, WRIGHT RD: The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocrinol Metab 32:575-578, 1971
25. 25. ALBRECHT D, BROSER M, KRUGER H: Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats. Regul Pept 70:105-109, 1997
26. 26. DULIN N, MADHUN ZT, CHANG CH, BERH-MATTERA L, DICKENS D, DOUGLAS JG: Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol 269:F644-F652, 1995
27. 27. NAVERI L, STROMBERG C, SAAVEDRA JM: Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 14:1096-1099, 1994
28. 28. NOSSAMAN BD, FENG CJ, KAYE AD, KADOWITZ PJ: Analysis of responses to ANG IV: Effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat. Am J Physiol 268:L302-L308, 1995
29. 29. WRIGHT JW, MILLER-WING AV, SHAFFER MJ, HIGGINSON C, WRIGHT DE, HANESWORTH JM, HARDING JW: Angiotensin II (3-8) (Ang IV) hippocampal binding: Potential role in the facilitation of memory. Brain Res Bull 32:497-502, 1993
30. 30. YANG Q, HANESWORTH JM, HARDING JW, SLINKER BK: The AT4 receptor agonist [Nlel]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart. Regul Pept 71:175-183, 1997
31. 31. KERINS DM, HAO Q, VAUGHAN DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 96:2515-2520, 1995
32. 32. EITZMAN DT, GINSBURG D: Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo. Adv Exp Med Biol 425:131-141, 1997
33. 33. SCHENA FP, GESUALDO L, GRANDALIANO G, MONTINARO V: Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int 52:1439-1457, 1997
34. 34. OIKAWA T, FREEMAN M, LO W, VAUGHAN DE, FOGO A: Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164-172, 1997
35. 35. DUYMELINCK C, DAUWE SE, NOUWEN EJ, DE BROE ME, VERPOOLEN GA: Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1. Kidney Int 51:1818-1830, 1997
36. 36. XU Y, HAGEGE J, MOUGENOT B, SRAER JD, RONNE E, RONDEAU E: Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 50:2011-2019, 1996
37. 37. RYAN MJ, JOHNSON G, KIRK J, FUERSTENBERG SM, ZAGER RA, TOROK-STORB B: HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48-57, 1994
38. 38. RACUSEN LC, MONTEIL C, SGRIGNOLI A, LUCSKAY M, MAROUILLAJ S, RHIM JGS, MORIN JP: Cell lines with extended in vitro growth potential from human renal proximal tubule: Characterization, response to inducers, and comparison with established cell lines. J Lab Clin Med 129:318-329, 1997
39. 39. DETRISAC C, SENS M, GARVIN A, SPICER S, SENS D: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25:383-390, 1984
40. 40. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
41. 41. COLUCCI M, GESUALDO L, MONTEMURRO P, CAVALLO LG, CONESE M, MASCOLO E, RANIERI E, DI PAOLO S, SCHENA FP, SEMERARO N: Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors. Thromb Haemost 74:1516-1520, 1995
42. 42. SCHLEEF RR, PODOR TJ, DUNNE E, MIMURO J, LOSKUTOFF DJ: The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Cell Biol 110:155-163, 1990
43. 43. KUGLER P: Localization of aminopeptidase A (angiotensinase A) in the rat and mouse kidney. Histochemistry 72:269-278, 1981
44. 44. RONCO P, ANTOINE M, BAUDOUIN B, GENITEAU-LEGENDRE M, LELONGT B, CHATELET F, VERROUSI P, VANDEWALLE A: Polarized membrane expression of brush-border hydrolases in primary cultures of kidney proximal tubular cells depends on cell differentiation and is induced by dexamethasone. J Cell Physiol 145:222-237, 1990
45. 45. AHMAD S, WARD PE: Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 252:643-650, 1990
46. 46. HARDING JW, WRIGHT JW, SWANSON GN, HANESWORTH JM, KREBS LT: AT4 receptors: Specificity and distribution. Kidney Int 46:1510-1512, 1994
47. 47. ARDAILLOU R, CHANSEL D: Angiotensin IV, a new component of the renin-angiotensin system, which acts on kidney cells. Bull Acad Natl Med 180:475-486, 1996
48. 48. BRASIER AR, LI J, WIMBISH KA: Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 27:1009-1017, 1996
49. 49. MORRISSEY JJ, KLAHR S: Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteraL obstruction. Kidney Int 52:926-933, 1997
50. 50. VAUGHAN DE: The renin-angiotensin system and fibrinolysis. Am J Cardiol 79:12-16, 1997
51. 51. RIDKER PM, GABOURY CL, CONLIN PR, SEELY EW, WILLIAMS GH, VAUGHAN DE: Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 87:1969-1973, 1993
52. 52. KEETON M, AHN C, EGUCHI V, BURLINGAME R, LOSKUTOFF DJ: Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis. Kidney Int 47:148-157, 1995
53. 53. WANG Y, PRATI JR, HARTLEY B, EVANS B, ZHANG L, SACKS SH: Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure. Kidney Int 52:371-377, 1997
54. 54. WILSON HM, HAITES NE, BOOTH NA: Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells. Nephron 77:197-204, 1997
55. 55. KLAHR S, ISHIDOYA S, MORRISSLEY J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146, 1995
56. 56. KLAHR S, MORRISSEY J: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31:171-176, 1998
57. 57. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
58. 58. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, KLAHR S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119, 1996
59. 59. RUGGENENTI P, REMUZZI G: Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease. Curr Opin Nephrol Hypertens 6:489-495, 1997
60. 60. NISHIMURA H, TSUJI H, MASUDA H, NAKAGAWA K, NAKAHARA Y, KITAMURA H, KASAHARA T, SUGANO T, YOSHIZUMI M, SAWADA S, NAKAGAWA M: Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 77:1189-1195, 1997
61. 61. YU K, LU D, PADDY MR, LENK SE, RAIZADA MK: Angiotensin II regulation of plasminogen activator inhibitor-1 gene expression in neurons of normotensive and spontaneously hypertensive rat brains. Endocrinology 137:2503-2513, 1996
62. 62. VAN LEEUWEN RT, KOL A, ANDREOTTI F, KLUFT C, MASERI A, SPERTI G: Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 90:362-368, 1994
63. 63. RYDZEWSKI B, ZELEZNA B. TANG W, SUMNERS C, RAIZADA MK: Angiotensin II stimulation of plasminogen activator inhibitor-1 gene expression in astroglial cells from the brain. Endocrinology 130:1255-1262, 1992
64. 64. SOEJIMA H, OGAWA H, YASUE H, SUEFUJI H, KAIKITA K, NISHIYAMA K: Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction. Clin Cardiol 20:441-445, 1997
65. 65. DUETZ R, OSTERZIEL KJ: New aspects of ACE inhibitor treatment of heart failure. Z Kardiol 85(Suppl 6):241-246, 1996
66. 66. WRIGHT RA, FLAPAN AD, ALBERTI KG, LUDLAM CA, FOX KA: Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol 24:67-73, 1994
67. 67. PEDERSEN OD, GRAM J, JEUNEMAFFRE X, BILLAUD E, JESPERSEN J: Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis 8:283-291, 1997